OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $773,776 | -35.6% | 246,425 | +5.9% | 0.00% | – |
| Q2 2023 | $1,201,067 | -80.7% | 232,765 | -80.3% | 0.00% | -100.0% |
| Q1 2023 | $6,227,575 | +418.0% | 1,181,703 | +176.2% | 0.00% | – |
| Q4 2022 | $1,202,319 | +53.7% | 427,872 | +127.2% | 0.00% | – |
| Q3 2022 | $782,000 | -15.0% | 188,313 | -17.8% | 0.00% | – |
| Q2 2022 | $920,000 | -16.1% | 229,141 | +3.4% | 0.00% | – |
| Q1 2022 | $1,097,000 | -62.7% | 221,661 | -47.5% | 0.00% | – |
| Q4 2021 | $2,944,000 | -54.6% | 422,372 | -34.9% | 0.00% | -100.0% |
| Q3 2021 | $6,488,000 | -7.0% | 648,815 | +31.9% | 0.00% | 0.0% |
| Q2 2021 | $6,974,000 | +27.1% | 491,867 | +47.1% | 0.00% | 0.0% |
| Q1 2021 | $5,486,000 | +1.2% | 334,326 | +27.6% | 0.00% | 0.0% |
| Q4 2020 | $5,422,000 | +169.2% | 261,917 | -1.0% | 0.00% | – |
| Q3 2020 | $2,014,000 | +23.3% | 264,627 | +34.9% | 0.00% | – |
| Q2 2020 | $1,634,000 | +119.9% | 196,113 | +30.6% | 0.00% | – |
| Q1 2020 | $743,000 | -21.2% | 150,132 | -37.1% | 0.00% | – |
| Q4 2019 | $943,000 | +64.6% | 238,721 | +26.7% | 0.00% | – |
| Q3 2019 | $573,000 | -26.3% | 188,386 | +6.8% | 0.00% | – |
| Q2 2019 | $777,000 | -15.2% | 176,464 | -23.5% | 0.00% | – |
| Q1 2019 | $916,000 | -29.0% | 230,617 | -28.9% | 0.00% | – |
| Q4 2018 | $1,290,000 | -26.5% | 324,280 | +27.2% | 0.00% | – |
| Q3 2018 | $1,754,000 | -6.5% | 254,965 | -8.2% | 0.00% | -100.0% |
| Q2 2018 | $1,875,000 | +5.8% | 277,796 | +2.1% | 0.00% | – |
| Q1 2018 | $1,772,000 | +53.7% | 272,155 | +5.1% | 0.00% | – |
| Q4 2017 | $1,153,000 | -31.0% | 258,925 | -4.2% | 0.00% | -100.0% |
| Q3 2017 | $1,670,000 | -54.9% | 270,288 | -32.3% | 0.00% | 0.0% |
| Q2 2017 | $3,700,000 | -67.0% | 399,070 | -67.0% | 0.00% | -50.0% |
| Q1 2017 | $11,222,000 | +104.0% | 1,209,272 | +84.0% | 0.00% | +100.0% |
| Q4 2016 | $5,500,000 | +39.7% | 657,372 | +14.7% | 0.00% | 0.0% |
| Q3 2016 | $3,938,000 | +707.0% | 573,309 | +481.4% | 0.00% | – |
| Q2 2016 | $488,000 | +121.8% | 98,606 | +332.1% | 0.00% | – |
| Q1 2016 | $220,000 | +272.9% | 22,822 | +265.2% | 0.00% | – |
| Q4 2015 | $59,000 | -39.8% | 6,250 | -10.6% | 0.00% | – |
| Q3 2015 | $98,000 | -73.5% | 6,988 | -60.3% | 0.00% | – |
| Q2 2015 | $370,000 | -52.7% | 17,604 | -5.6% | 0.00% | – |
| Q1 2015 | $783,000 | +116.9% | 18,642 | +21.5% | 0.00% | – |
| Q4 2014 | $361,000 | -63.6% | 15,348 | -76.8% | 0.00% | – |
| Q3 2014 | $992,000 | – | 66,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |